High molecular response rate and overall survival with FLT3 inhibitors as MRD-guided salvage treatment for molecular failure in AML
Othman, J. Potter, N. Mokretar, K. Taussig, D. Khan, A. Krishnamurthy, P. Latif, A. L. Cahalin, P. Aries, J. Amer, M.
Othman, J.
Potter, N.
Mokretar, K.
Taussig, D.
Khan, A.
Krishnamurthy, P.
Latif, A. L.
Cahalin, P.
Aries, J.
Amer, M.
Citations
Altmetric:
Abstract
Authors
Othman, J.
Potter, N.
Mokretar, K.
Taussig, D.
Khan, A.
Krishnamurthy, P.
Latif, A. L.
Cahalin, P.
Aries, J.
Amer, M.
Belsham, E.
Conneally, E.
Craddock, C.
Culligan, D.
Dennis, Michael
Duncan, C.
Furness, C.
Gkreka, P.
Hodgson, K.
Ingram, W.
King, A.
Kottaridis, P.
McMullin, M. F.
Mohite, U.
Ngu, L.
Patrick, K.
Rider, T.
Roberts, W.
Severinsen, M. T.
Storrar, N.
Taylor, T.
Russell, N. H.
Dillon, R.
Potter, N.
Mokretar, K.
Taussig, D.
Khan, A.
Krishnamurthy, P.
Latif, A. L.
Cahalin, P.
Aries, J.
Amer, M.
Belsham, E.
Conneally, E.
Craddock, C.
Culligan, D.
Dennis, Michael
Duncan, C.
Furness, C.
Gkreka, P.
Hodgson, K.
Ingram, W.
King, A.
Kottaridis, P.
McMullin, M. F.
Mohite, U.
Ngu, L.
Patrick, K.
Rider, T.
Roberts, W.
Severinsen, M. T.
Storrar, N.
Taylor, T.
Russell, N. H.
Dillon, R.
Description
Date
2022
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Othman J, Potter N, Mokretar K, Taussig D, Khan A, Krishnamurthy P, et al. High Molecular Response Rate and Overall Survival with FLT3 Inhibitors As MRD-Guided Salvage Treatment for Molecular Failure in AML. Blood. 2022 Nov;140:2002-4. PubMed PMID: WOS:000893223202004.